A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health.


Journal

Nutrition research (New York, N.Y.)
ISSN: 1879-0739
Titre abrégé: Nutr Res
Pays: United States
ID NLM: 8303331

Informations de publication

Date de publication:
06 2020
Historique:
received: 22 09 2019
revised: 24 02 2020
accepted: 06 03 2020
pubmed: 20 5 2020
medline: 26 5 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

The potential benefits of supplemental nutrients and dietary interventions against cardiovascular morbidity and mortality have been extensively investigated throughout the years. Numerous supplements claim cardioprotection and reduction of cardiovascular risk factors, but the roles of many supplements have not been determined. In the vast number of supplements on the market asserting cardioprotective effects, only 3 have been thoroughly evaluated and consistently reported as effective by our clinic patients. They have used supplements such as fish oil, multivitamins, and calcium, but many had not known of the benefits of resveratrol, curcumin, and nitric oxide as supplements for improving cardiovascular health. The cardioprotective effects of these dietary supplements in both animal models and humans have been explored with proposed mechanisms of action mostly attributed to antioxidant and anti-inflammatory properties. Resveratrol is one of the most studied polyphenols with established cardiovascular benefits. Preclinical studies have demonstrated these effects exerted via improved inflammatory markers, atherogenic profile, glucose metabolism, and endothelial function and are further supported by clinical trials. Curcumin has a well-established anti-inflammatory role by regulating numerous transcription factors and cytokines linked to inflammation. Inflammation is an underlying pathology in cardiovascular diseases, rendering curcumin a potential therapeutic compound. Similarly, nitric oxide supplementation has demonstrated cardiovascular benefits by normalizing blood pressure; enhancing blood flow; and reducing inflammation, immune dysfunction, and oxidative stress. A comprehensive review was performed evaluating the cardioprotective effects of these 3 dietary supplements with hope to provide updated information, promote further awareness of these supplements, and inspire future studies on their effects on cardiovascular health.

Identifiants

pubmed: 32428778
pii: S0271-5317(19)30880-2
doi: 10.1016/j.nutres.2020.03.002
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Antioxidants 0
Cardiotonic Agents 0
Nitric Oxide 31C4KY9ESH
Curcumin IT942ZTH98
Resveratrol Q369O8926L

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-26

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Melissa J Banez (MJ)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: melissabanez@southerncaliforniahospitalheartinstitute.com.

Matthew I Geluz (MI)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: matthewgeluz@southerncaliforniahospitalheartinstitute.com.

Anjali Chandra (A)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: anjalichandra@southerncaliforniahospitalheartinstitute.com.

Tesnim Hamdan (T)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: tesnimhamdan@southerncaliforniahospitalheartinstitute.com.

Olivia S Biswas (OS)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: oliviabiswas@southerncaliforniahospitalheartinstitute.com.

Nathan S Bryan (NS)

Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: nathan@drnathansbryan.com.

Ernst R Von Schwarz (ER)

Southern California Hospital Heart Institute, 3831 Hughes Ave, Suite 105, Culver City, CA 90232. Electronic address: ernstvonschwarz@southerncaliforniahospitalheartinstitute.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH